SCHEMBL13633522

SCHEMBL13633522

Cc1noc(-c2cc(-c3cccnc3)cc3nc(N)cn23)n1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
TP53 P04637 3/20 0.39
ALDH1A1 P00352 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PPARA Q07869 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA5 P30532 1/20 0.39
CHRNA4 P43681 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
AHR P35869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13633556 0.77
SCHEMBL5256464 0.72 CHRNB2 (0.69) SMN1; SMN2TP53ALDH1A1NFKB1NFKB2
SCHEMBL3914106 0.68 ABL1 (0.44)
SCHEMBL13823146 0.67 SMN1; SMN2 (0.46) SMN1; SMN2TP53ALDH1A1NFKB1NFKB2
SCHEMBL7676404 0.65 SMN1; SMN2 (0.49) SMN1; SMN2TP53ALDH1A1NFKB1NFKB2
SCHEMBL3911140 0.64 KDM4E (0.44) SMN1; SMN2TP53ALDH1A1NPC1RAB9A
SCHEMBL3909975 0.62 KDM4E (0.57) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL22629459 0.61 PARP1 (0.49) SMN1; SMN2TP53ALDH1A1NFKB1NFKB2
SCHEMBL9446750 0.61 CHRNB2 (0.69) SMN1; SMN2TP53ALDH1A1NFKB1NFKB2
SCHEMBL61991 0.60 ACHE (0.64) SMN1; SMN2TP53ALDH1A1NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL SMN1; SMN2 2248/4885TP53 4454/4885ALDH1A1 637/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA SMN1; SMN2 1846/4885TP53 3522/4885ALDH1A1 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.